From: Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases
KRAS-wt
n = 63
KRAS-mut
n = 38
P-value
Total cohort
49/63 (77.8%)
33/38 (86.8%)
0.304
Synchronous metastases
26/34 (76.5%)
20/22 (90.9%)
0.285
Metachronous metastases
23/29 (79.3%)
13/16 (81.3%)
1.000